Navigation Links
Care-Tech Laboratories Agrees to Stop Making, Selling and Distributing Unapproved Antimicrobial Products
Date:9/8/2009

WASHINGTON, Sept. 8 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today announced that St. Louis-based Care-Tech Laboratories Inc. and its principal officers, John C. Brereton and Sherry L. Brereton, have signed a consent decree, agreeing to stop the illegal manufacture, marketing, and distribution of over-the-counter (OTC) antimicrobial drugs used to treat and prevent infection.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO)

Inspectors found that Care-Tech violated numerous provisions of the FDA's current good manufacturing practice (cGMP) regulations that direct how antimicrobial drugs are made. Additionally, the products do not conform to any applicable regulations for OTC drug products and have not undergone an FDA review, and therefore are considered unapproved drug products.

Under the terms of the consent decree, Care-Tech may not resume manufacturing and distribution of the drugs until it corrects these and other violations.

"The FDA is concerned about Care-Tech's products because they lack FDA approval, do not conform to any applicable over-the-counter drug monograph, and are not appropriately manufactured," said Deborah Autor, director of the FDA's Office of Compliance, Center for Drug Evaluation and Research. "Companies have an obligation to consumers to ensure that their products are safe, effective, and high quality, and the FDA recommends that Care-Tech's customers seek alternative products."

Care-Tech products are sold online and through telephone orders to hospitals, nursing homes and other health care facilities. They are not sold in retail stores. The FDA is not aware of any reports of injury or illness related to the use of these products. Consumers should contact Care-Tech at 1-800-325-9681 to return products in their possession, which include:

Barri-Care

Care-Creme

Caricia Care

CC-500

Clinical Care

Consept

Formula Magic

Humatrix

Loving Lather

Loving Lather II

Loving Lotion

Orchid Fresh II

Satin

Tech 2000

Techni-Care

Urban Skin

Health care professionals and consumers may report serious adverse events (side effects) or quality problems for these or any products to the FDA's MedWatch Adverse Event Reporting program, online, or by regular mail, fax or phone.

For more information:

Facts About Current Good Manufacturing Practices (cGMPs)

Media Inquiries: Christopher Kelly, 301-796-4676, christopher.kelly@fda.hhs.gov

Consumer Inquiries: 888-INFO-FDA


'/>"/>
SOURCE U.S. Food and Drug Administration
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces Reversal of Summary Judgment in Ultracet(R) ANDA Patent Litigation
2. Breckenridge Pharmaceutical Enters Agreement with Orit Laboratories (West Caldwell, NJ) to Market Ergocalciferol (Vitamin D) Capsules
3. AUDIO from Medialink and Forest Laboratories: Dangers of Switching Medications
4. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Imitrex(R) Tablets
5. Nycomed and Forest Laboratories to Collaborate on US Commercialisation of Daxas(R) in COPD
6. Caraco Pharmaceutical Laboratories, Ltd. Announces Settlement of Ethyol(R) ANDA Patent Litigation
7. Roxane Laboratories, Inc. Announces the Launch of Risperidone Oral Solution 1mg/mL
8. Caraco Pharmaceutical Laboratories, Ltd. Announces Change to Executive Team as Jitendra N. Doshi Assumes Position of CEO
9. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2010
10. Leading health organizations launch new accreditation process for laboratories across Africa
11. IDEXX Laboratories Announces Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... ... August 17, 2017 , ... Georgia Urology, ... Dr. Kristi Hebert to its newest location in East Cobb (4800 ... Dr. Hebert come aboard,” said Dr. Mark A. Haber, Georgia Urology’s managing partner. “She ...
(Date:8/17/2017)... Houston, Texas (PRWEB) , ... August 17, 2017 ... ... Dr. Rukmini “Vinaya” Rednam distinguishes herself once more by being among Houston’s first ... clientele receives the highest quality plastic surgery care without disrupting busy schedules and ...
(Date:8/17/2017)... ... ... SeQuel Response announced today that for the fourth consecutive year, ... companies in the U.S., putting it in the top 10 percent of applicants nationwide. ... Inc. 5000 over the years, only a fraction have made the list more ...
(Date:8/17/2017)... ... 2017 , ... CareAcademy, a provider of specialized online training ... in seed funding to further expand its course portfolio and increase its market ... the company’s primary investors. , Founded in 2016, CareAcademy currently serves ...
(Date:8/17/2017)... Ca (PRWEB) , ... August 17, 2017 , ... Centrifugation ... useful tools in the laboratory that we can no longer do without. And just ... the lifetime of your device. , In this webinar, attendees will learn about the ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... Second-quarter 2017 revenues of $876 ... from continuing operations Second-quarter ... $110 million Second-quarter 2017 ... Second-quarter 2017 adjusted diluted ... percent to $0.93 Second-quarter ...
(Date:8/7/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) today ... effective Aug. 7, 2017. ... interests and will serve as president emeritus during a planned, ... in multiple leadership roles since he joined Diplomat with the ... provided decisive, strategic leadership which continues to benefit our patients ...
(Date:8/4/2017)... , Aug. 4, 2017 The search ... shortly after a physician/patient consult has long been the ... was a notable focus of the largest meeting of ... according to healthcare market research firm Kalorama Information.  The ... testing (POCT) offerings or related supplies and software were ...
Breaking Medicine Technology: